ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases. oleh Gandhi Damaj, Magalie Joris, Olivia Chandesris, Katia Hanssens, Erinn Soucie, Danielle Canioni, Brigitte Kolb, Isabelle Durieu, Emanuel Gyan, Cristina Livideanu, Stephane Chèze, Momar Diouf, Reda Garidi, Sophie Georgin-Lavialle, Vahid Asnafi, Ludovic Lhermitte, Christian Lavigne, David Launay, Michel Arock, Olivier Lortholary, Patrice Dubreuil, Olivier Hermine